pharma news today obesity drugs glp-1 october 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo The outlook for obesity from

Discover how GLP-1 and GLP-1/GIP therapies (semaglutide and tirzepatide) influence body composition

IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits

The convergence of chronic inflammation, mitochondrial dysfunction and altered protein metabolism makes individuals with metabolic diseases particularly vulnerable to sarcopenia

Many people are familiar with the concept of microdosing when it comes to psychedelic drugsbut a new trend is emerging in the world of weight loss and weight management: microdosing GLP-1 medications

The Semaglutide Weight Loss Program is a clinician-guided telehealth program built around compounded semaglutide, a GLP-1 medication that supports appetite control, quiets food noise, and makes a calorie deficit easier to sustain

Each category lists specific foods that can help increase GLP1 levels